Skip to content

Identifying Vitamin D Deficiency in Very Low Birth Weight Infant (VLBW) Infants Part 2

Identifying Vit D Deficiency in VLBW Infants Part 2

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01363167
Enrollment
68
Registered
2011-06-01
Start date
2011-10-31
Completion date
2013-10-31
Last updated
2014-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Calcium Deficiency, Infant, Very Low Birth Weight, Vitamin D Deficiency

Keywords

vitamin D, preterm infants, calcium, bone, parathyroid hormone

Brief summary

This study is to determine the amount of vitamin D required for a very low birth weight infant to reach vitamin D sufficiency and achieve optimal calcium health and bone growth.

Interventions

DIETARY_SUPPLEMENT400 IU Cholecalciferol- Vitamin D Daily

Infants who are defined as vitamin D deficient at birth will be randomized to receive either 400 IU vitamin D/day or placebo daily until term age is reached.

Sponsors

National Center for Research Resources (NCRR)
CollaboratorNIH
Medical University of South Carolina
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
1 Days to 3 Days
Healthy volunteers
No

Inclusion criteria

* Any infant born at the Medical University of South Carolina \<34 weeks gestation * Less that 1500g at birth * AGA * Must be African American or Caucasian * Each infant born of twin and triplet pregnancies will be eligible

Exclusion criteria

* Infants with major congenital anomalies or with hemolytic disease requiring exchange transfusion * Infants born small for-gestational-age (SGA) or large for-gestational-age (LGA) * Maternal uncontrolled thyroid disease * Maternal Parathyroid disease * Infants of races other than African American or Caucasian

Design outcomes

Primary

MeasureTime frameDescription
Serum inflammatory cytokine concentrationsAt birth (day 1)
Parathyroid hormone concentrationAt term age (expected 2-4 months)
Serum 25 hydroxyvitamin D statusAt term age (expected 2-4 months)
Bone HealthAt term age (expected 2-4 months)Bone ultrasound measurement, serum alkaline phosphatase, and bone-specific alkaline phosphatase at birth and monthly until term age. Bone mineralization by DEXA scan at hospital discharge and term age.
Intestinal Calcium AbsorptionWhen receiving at least 50% of nutrition enterally expected to occur at 2-6 weeks post-birth

Secondary

MeasureTime frameDescription
Growth parametersAt term age (expected 2-4 months)
Vitamin D Dose Safety as Measured by Urinary Calcium ExcretionAt term age (expected 2-4 months)
Phosphorus HomeostasisAt term age (expected 2-4 months)Measurement of serum and urine phosphorus concentrations

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026